Bristol-Myers Squibb Company ( BMY) - Key Metrics
BMY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.13 | $0.53 | ? | ? |
| 2025Q3 | $6 | $1.08 | $3.10 | $2.94 |
| 2025Q2 | $6.03 | $0.64 | $1.92 | $1.75 |
| 2025Q1 | $5.52 | $1.21 | $0.96 | $0.83 |
BMY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 116.52% | 25.34 |
| 2025Q3 | 57.38% | 10.44 |
| 2025Q2 | 96.34% | 17.98 |
| 2025Q1 | 51.22% | 12.61 |
BMY Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.61% | ? |
| 2025Q4 | 1.46% | 1.15% |
| 2025Q3 | 6.52% | 1.37% |
| 2025Q2 | 3.77% | 1.34% |
| 2025Q1 | 1.37% | 1.02% |
BMY
List: Contenders
Price: $57.66
Dividend Yield: 4.43%
Forward Dividend Yield: 4.35%
Payout Ratio: -73.85%
Dividend Per Share: 2.52 USD
Earnings Per Share: 3.57 USD
P/E Ratio: 15.85
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 10.2 million
Ebitda: 946.0 millionMarket Capitalization: 115.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 55
DGR3: 5.26%
DGR5: 6.95%
DGR10: 5.32%
DGR20: 4.05%